These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2897472)

  • 21. Correlation between phenotypic characteristics of mononuclear cells isolated from human periapical lesions and their in vitro production of Th1 and Th2 cytokines.
    Colić M; Lukić A; Vucević D; Milosavljević P; Majstorović I; Marjanović M; Dimitrijević J
    Arch Oral Biol; 2006 Dec; 51(12):1120-30. PubMed ID: 16797478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of a flow cytometric cytotoxicity assay for monitoring cancer vaccine trials.
    Zaritskaya L; Shafer-Weaver KA; Gregory MK; Strobl SL; Baseler M; Malyguine A
    J Immunother; 2009; 32(2):186-94. PubMed ID: 19238018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphocyte-mediated cytotoxicity against allogeneic tumour cells. IV. Fine specificity mapping and characterization of concanavalin A-activated cytotoxic effector lymphocytes.
    Waterfield JD; Nixon DF; Mair MG
    Immunology; 1981 Dec; 44(4):685-93. PubMed ID: 6797935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of altered membrane fluidity on NK cell-mediated cytotoxicity. I. Selective inhibition of the recognition or post recognition events in the cytolytic pathway of NK cells.
    Roozemond RC; Bonavida B
    J Immunol; 1985 Apr; 134(4):2209-14. PubMed ID: 3855929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum-free culture of dendritic cells from patients with chronic myeloid leukemia in vitro and estimation of their cytotoxicity.
    Zhao W; Xing P; Wei X; Wang T; Yang D; Li M
    Chin Med J (Engl); 2002 Sep; 115(9):1296-300. PubMed ID: 12411098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Temporal reduction in acute rejection after heart transplantation is not associated with a reduction in cell-mediated responses to donor-specific vascular endothelium.
    Hosenpud JD; Shipley GD; Mauck KA; Morris TE; Wagner CR
    J Heart Lung Transplant; 1995; 14(5):926-37. PubMed ID: 8800729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purification and target cell range of in vivo elicited blast natural killer cells.
    Biron CA; Pedersen KF; Welsh RM
    J Immunol; 1986 Jul; 137(2):463-71. PubMed ID: 3722814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
    Neville ME; Hiserodt JC
    J Immunol; 1982 Mar; 128(3):1246-51. PubMed ID: 6976989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Autologous mixed lymphocyte culture (AMLC)].
    Volk HD; Grunow R
    Allerg Immunol (Leipz); 1984; 30(2):60-73. PubMed ID: 6237558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Initial characterization of a lymphokine pathway for the immunologic induction of tumor necrosis factor-alpha release from human peripheral blood mononuclear cells.
    Kornbluth RS; Gregory SA; Edgington TS
    J Immunol; 1988 Sep; 141(6):2006-15. PubMed ID: 3139748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of the mechanism of allograft rejection and cell-mediated immunity. I. Accelerated rejection of tumour allografts without augmented cytotoxicity in the spleen cells.
    Nanishi F; Nomoto K; Taniguchi K; Kubo C
    Immunology; 1980 May; 40(1):67-76. PubMed ID: 7419243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spontaneous tumor cell cytotoxicity mediated by peripheral blood mononuclear leukocytes of the dog.
    Büttner M; Schumm M; Boenisch B; Rieber EP; Kolb HJ
    Nat Immun; 1993; 12(2):92-103. PubMed ID: 8318818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two-color flow cytometry and functional analysis of lymphocytes cultured from human renal allografts: identification of a Leu-2+3+ subpopulation.
    Preffer FI; Colvin RB; Leary CP; Boyle LA; Tuazon TV; Lazarovits AI; Cosimi AB; Kurnick JT
    J Immunol; 1986 Nov; 137(9):2823-30. PubMed ID: 3093583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased cytotoxicity and CD16 (Leu 11) expression in long-term, IL-2-activated human peripheral blood mononuclear cells.
    Podack ER; Penichet KO; Lin BY; Chiao JW; Mittelman A
    Blood Cells; 1987; 13(1-2):117-22. PubMed ID: 3311212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural killing and growth inhibition of K562 cells by subpopulations of mononuclear cells as a function of target cell proliferation.
    Hagner G
    Immunology; 1984 Jul; 52(3):555-62. PubMed ID: 6611299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation and characterization of cytotoxic effector cells and antibody producing cells from human intestine.
    MacDermott RP
    Acta Chir Scand Suppl; 1985; 525():25-43. PubMed ID: 3875204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative study of NK cell-mediated cytotoxicity using radioactive and flow cytometric cytotoxicity assays.
    Langhans B; Ahrendt M; Nattermann J; Sauerbruch T; Spengler U
    J Immunol Methods; 2005 Nov; 306(1-2):161-8. PubMed ID: 16202423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the immunogenicity of freeze-dried skin allografts in humans: cell-mediated response.
    Gher ME; Vernino AR; Maluish AE; Strong DM
    J Periodontol; 1982 May; 53(5):325-7. PubMed ID: 7045323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Granulocytes as effectors in cell-mediated cytotoxicity of adherent target cells.
    Takasugi M; Akira D; Kinoshita K
    Cancer Res; 1975 Aug; 35(8):2169-76. PubMed ID: 1149032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel micro-cell-mediated lympholytic assay for the evaluation of regulatory cells in human alloreactive CTL responses.
    Mathew JM; Blomberg B; Fuller L; Burke GW; Ciancio G; Kenyon N; Ricordi C; Tzakis AG; Esquenazi V; Miller J
    J Immunol Methods; 2003 Jan; 272(1-2):67-80. PubMed ID: 12505713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.